These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 36899347

  • 21. Pharmacologic management of the older patient with type 2 diabetes mellitus.
    Neumiller JJ, Setter SM.
    Am J Geriatr Pharmacother; 2009 Dec; 7(6):324-42. PubMed ID: 20129254
    [Abstract] [Full Text] [Related]

  • 22. Evaluation of Frailty as an Unmeasured Confounder in Observational Studies of Antidiabetic Medications.
    Presley CA, Chipman J, Min JY, Grijalva CG, Greevy RA, Griffin MR, Roumie CL.
    J Gerontol A Biol Sci Med Sci; 2019 Jul 12; 74(8):1282-1288. PubMed ID: 30256914
    [Abstract] [Full Text] [Related]

  • 23. Geographic Variation in Antidiabetic Agent Adherence and Glycemic Control Among Patients with Type 2 Diabetes.
    Tan E, Yang W, Pang B, Dai M, Loh FE, Hogan P.
    J Manag Care Spec Pharm; 2015 Dec 12; 21(12):1195-202. PubMed ID: 26679968
    [Abstract] [Full Text] [Related]

  • 24. Newer anti-diabetic therapies with low hypoglycemic risk-potential advantages for frail older people.
    Emmerton D, Abdelhafiz A.
    Hosp Pract (1995); 2021 Aug 12; 49(3):164-175. PubMed ID: 33729898
    [Abstract] [Full Text] [Related]

  • 25. Time to modification of antidiabetic therapy in patients over the age of 65 years with newly diagnosed diabetes mellitus.
    Machado-Alba JE, Machado-Duque ME, Gaviria-Mendoza A.
    Diabetes Res Clin Pract; 2020 Apr 12; 162():108090. PubMed ID: 32088311
    [Abstract] [Full Text] [Related]

  • 26. [Characterization of and costs associated to the profile of patients with type 2 diabetes treated with metformin who are added a second oral antidiabetic drug: a population study].
    Sicras-Mainar A, Font-Ramos B, Roldán-Suárez C, Navarro-Artieda R, Ibáñez-Nolla J.
    Endocrinol Nutr; 2013 Dec 12; 60(10):557-69. PubMed ID: 24008167
    [Abstract] [Full Text] [Related]

  • 27. Fasting plasma lactate concentrations in ambulatory elderly patients with type 2 diabetes receiving metformin therapy: a retrospective cross-sectional study.
    Lin YC, Lin LY, Wang HF, Lin HD.
    J Chin Med Assoc; 2010 Dec 12; 73(12):617-22. PubMed ID: 21145508
    [Abstract] [Full Text] [Related]

  • 28. Oral antidiabetic therapy in a large Italian sample: drug supply and compliance for different therapeutic regimens.
    Vittorino Gaddi A, Benedetto D, Capello F, Di Pietro C, Cinconze E, Rossi E, De Sando V, Cevenini M, D'Alò G.
    Public Health; 2014 Jan 12; 128(1):70-6. PubMed ID: 23969148
    [Abstract] [Full Text] [Related]

  • 29. Polypharmacy in elderly patients with type 2 diabetes receiving oral antidiabetic treatment.
    Noale M, Veronese N, Cavallo Perin P, Pilotto A, Tiengo A, Crepaldi G, Maggi S.
    Acta Diabetol; 2016 Apr 12; 53(2):323-30. PubMed ID: 26155958
    [Abstract] [Full Text] [Related]

  • 30. Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: a longitudinal cohort study.
    Balkrishnan R, Rajagopalan R, Camacho FT, Huston SA, Murray FT, Anderson RT.
    Clin Ther; 2003 Nov 12; 25(11):2958-71. PubMed ID: 14693318
    [Abstract] [Full Text] [Related]

  • 31. Antidiabetic therapy and the risk of heart failure in type 2 diabetic patients: an independent effect or confounding by indication.
    Koro CE, Bowlin SJ, Weiss SR.
    Pharmacoepidemiol Drug Saf; 2005 Oct 12; 14(10):697-703. PubMed ID: 15654719
    [Abstract] [Full Text] [Related]

  • 32. Evaluation of the frailty characteristics and clinical outcomes according to the new frailty-based outcome prediction model (Myeloma Risk Profile-MRP) in a UK real-world cohort of elderly newly diagnosed Myeloma patients.
    Djebbari F, Rampotas A, Panitsas F, Lim WY, Lees C, Tsagkaraki I, Gomes AR, Prideaux S, Chen L, Prodger C, Khera A, Gray N, Ellis L, Sangha G, Eyre TA, Moore S, Kothari J, Ramasamy K.
    PLoS One; 2022 Oct 12; 17(1):e0262388. PubMed ID: 35015781
    [Abstract] [Full Text] [Related]

  • 33. Antidiabetic Treatment, Level of Glycemic Control, and Risk of Fracture in Type 2 Diabetes: a Nested, Case-Control Study.
    Charlier S, Vavanikunnel J, Becker C, Jick SS, Meier C, Meier CR.
    J Clin Endocrinol Metab; 2021 Jan 23; 106(2):554-566. PubMed ID: 33141149
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Risks of cardiovascular diseases associated with dipeptidyl peptidase-4 inhibitors and other antidiabetic drugs in patients with type 2 diabetes: a nation-wide longitudinal study.
    Ou HT, Chang KC, Li CY, Wu JS.
    Cardiovasc Diabetol; 2016 Mar 01; 15():41. PubMed ID: 26932742
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Medication Adherence Affects Risk of New Diabetes Complications: A Cohort Study.
    Simpson SH, Lin M, Eurich DT.
    Ann Pharmacother; 2016 Sep 01; 50(9):741-6. PubMed ID: 27307411
    [Abstract] [Full Text] [Related]

  • 39. Measuring adherence to oral antidiabetic multi-drug treatment: Comparative validity of prescription claims-based adherence measures against hospitalization.
    Zongo A, Grégoire JP, Moisan J, Guénette L.
    Res Social Adm Pharm; 2019 Jun 01; 15(6):738-743. PubMed ID: 30253976
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.